Ambrx Biopharma, Inc. Quarterly Operating Lease, Liability, Current in USD from Q4 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Ambrx Biopharma, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q4 2022 to Q3 2023.
  • Ambrx Biopharma, Inc. Operating Lease, Liability, Current for the quarter ending September 30, 2023 was $1.92M.
Operating Lease, Liability, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $1.92M Sep 30, 2023 10-Q 2023-11-13
Q4 2022 $1.73M Dec 31, 2022 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.